REFERENCES
1. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. The Lancet Oncology. 2006;7(10):813-820.
2. Packer RJ, Gajjar A, Vezina G, et al. Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma. Journal of Clinical Oncology.2006;24(25):4202-4208.
3. Merchant TE, Li C, Xiong X, Kun LE, Boop FA, Sanford RA. Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study. The Lancet Oncology. 2009;10(3):258-266.
4. Jensen AW, Laack NN, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma.International journal of radiation oncology, biology, physics.2010;77(5):1449-1456.
5. Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. 2010;28(4):E10.
6. Kahalley LS, Douglas Ris M, Mahajan A, et al. Prospective, longitudinal comparison of neurocognitive change in pediatric brain tumor patients treated with proton radiotherapy versus surgery only.Neuro-oncology. 2019;21(6):809-818.
7. Bavle A, Tewari S, Sisson A, Chintagumpala M, Anderson M, Paulino AC. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.Pediatric blood & cancer. 2018;65(8):e27095.
8. Eaton BR, Esiashvili N, Kim S, et al. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma.Neuro-oncology. 2016;18(6):881-887.
9. Whelan KF, Stratton K, Kawashima T, et al. Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study. Pediatric blood & cancer.2010;54(1):103-109.
10. Chodick G, Sigurdson AJ, Kleinerman RA, et al. The Risk of Cataract among Survivors of Childhood and Adolescent Cancer: A Report from the Childhood Cancer Survivor Study. Radiation research.2016;185(4):366-374.
11. Benyunes MC, Sullivan KM, Deeg HJ, et al. Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation. International journal of radiation oncology, biology, physics. 1995;32(3):661-670.
12. Ferry C, Gemayel G, Rocha V, et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone marrow transplantation. 2007;40(3):219-224.
13. Gurney JG, Ness KK, Rosenthal J, Forman SJ, Bhatia S, Baker KS. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study. Cancer.2006;106(6):1402-1408.
14. Horwitz M, Auquier P, Barlogis V, et al. Incidence and risk factors for cataract after haematopoietic stem cell transplantation for childhood leukaemia: an LEA study. Br J Haematol.2015;168(4):518-525.
15. van Kempen-Harteveld ML, Belkacémi Y, Kal HB, Labopin M, Frassoni F. Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia.International journal of radiation oncology, biology, physics.2002;52(5):1367-1374.
16. Zierhut D, Lohr F, Schraube P, et al. Cataract incidence after total-body irradiation. International journal of radiation oncology, biology, physics. 2000;46(1):131-135.
17. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment–results of an international workshop. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.2001;19(1):197-204.
18. Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology.2001;108(11):2116-2121.
19. Gondi V, Yock TI, Mehta MP. Proton therapy for paediatric CNS tumours — improving treatment-related outcomes. Nature Reviews Neurology. 2016;12(6):334-345.
20. Lühr A, von Neubeck C, Krause M, Troost EGC. Relative biological effectiveness in proton beam therapy - Current knowledge and future challenges. Clinical and translational radiation oncology.2018;9:35-41.
21. Alloin A-L, Barlogis V, Auquier P, et al. Prevalence and risk factors of cataract after chemotherapy with or without central nervous system irradiation for childhood acute lymphoblastic leukaemia: an LEA study. British Journal of Haematology. 2014;164(1):94-100.
22. Socié G, Salooja N, Cohen A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood.2003;101(9):3373-3385.
23. Parsons JT, Bova FJ, Mendenhall WM, Million RR, Fitzgerald CR. Response of the normal eye to high dose radiotherapy. Oncology (Williston Park, NY). 1996;10(6):837-847; discussion 847-838, 851-832.
24. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Severe dry-eye syndrome following external beam irradiation.International journal of radiation oncology, biology, physics.1994;30(4):775-780.